Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia

被引：2

作者：

Wang, Aiping ^{[1
]}

Li, Hang ^{[1
]}

Xie, Zhihong ^{[2
]}

Li, Lingfeng ^{[3
]}

Jiang, Xian ^{[4
]}

Guo, Qing ^{[5
]}

Hu, Fengming ^{[6
]}

Zhang, Jianzhong ^{[7
]}

Cui, Yong ^{[8
]}

Ding, Yangfeng ^{[9
]}

Fang, Hong ^{[10
]}

Han, Xiuping ^{[11
]}

Guo, Shuping ^{[12
]}

Wang, Junlong ^{[13
]}

Ni, Na ^{[13
]}

机构：

[1] Peking Univ First Hosp, Dermatol & Venereol Dept, Beijing, Peoples R China

[2] Beijing Hosp, Dermatol Dept, Beijing, Peoples R China

[3] Capital Med Univ, Beijing Friendship Hosp, Dermatol & Venereol Dept, Beijing, Peoples R China

[4] Sichuan Univ, West China Hosp, Dermatol & Venereol Dept, Chengdu, Peoples R China

[5] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dermatol Dept, Guangzhou, Peoples R China

[6] Dermatol Hosp Jiangxi Prov, Dept Integrated Chinese & Western Med, Nanchang, Peoples R China

[7] Peking Univ Peoples Hosp, Dermatol Dept, Beijing, Peoples R China

[8] China Japan Friendship Hosp, Dermatol Dept, Beijing, Peoples R China

[9] Shanghai Skin Dis Hosp, Dermatol Dept, Shanghai, Peoples R China

[10] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dermatol Dept, Hangzhou, Peoples R China

[11] China Med Univ, Shengjing Hosp, Dermatol Dept, Shenyang, Peoples R China

[12] Shanxi Med Univ, Hosp 1, Dermatol Dept, Taiyuan, Peoples R China

[13] China State Inst Pharmaceut Ind, Clin Res Ctr, Shanghai, Peoples R China

来源：

DERMATOLOGY AND THERAPY | 2023年 / 13卷 / 07期

关键词：

Lidocaine patch; Postherpetic neuralgia; Clinical study; Efficacy; Safety; LOCALIZED NEUROPATHIC PAIN; MEDICATED PLASTER;

D O I：

10.1007/s13555-023-00938-8

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

IntroductionTo evaluate the efficacy and safety of lidocaine patches in Chinese patients with postherpetic neuralgia (PHN).MethodsPatients were randomized to receive lidocaine patches or placebo every day for 4 weeks. Efficacy endpoints included the decrease of analogue scale score (VAS) value at week 4, 2 and 1 and the percentage of patients that achieved a 30% decrease of VAS value. Safety analyses were conducted as well.ResultsTwo hundred forty Chinese patients were randomized. At week 1, lidocaine patch-treated patients had a higher clinical response versus placebo, and at week 4, the mean (SD) decreases of VAS value compared to the baseline were 14.01 (14.35) in the treatment group and 9.36 (12.03) in the placebo group (p = 0.0088). Overall, the safety profile in the treatment group was consistent with that observed in the placebo group [adverse event (AE) incidence rate: 33.33% versus 37.29%, p = 0.5857].ConclusionsLidocaine patches resulted in improved clinical response versus placebo in the treatment of PHN patients and were well tolerated.

引用

页码：1477 / 1487

页数：11

共 50 条

[21] Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial
Rullan, Manuel
Bulilete, Oana
Leiva, Alfonso
Soler, Aina
Roca, Antonia
Jose Gonzalez-Bals, Maria
Lorente, Patricia
Llobera, Joan
TRIALS, 2017, 18
[22] Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial
Manuel Rullán
Oana Bulilete
Alfonso Leiva
Aina Soler
Antonia Roca
María José González-Bals
Patricia Lorente
Joan Llobera
Trials, 18
[23] Efficacy and safety of oxcarbazepine in patients with migraine headaches: A multicenter, double. blind, randomized, placebo-controlled study
Saper, J
Silberstein, S
Somogyi, M
McCague, K
NEUROLOGY, 2005, 64 (06) : A334 - A334
[24] Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial
Kato, Jitsu
Matsui, Norimitsu
Kakehi, Yoshihiro
Murayama, Emiko
Ohwada, Shoichi
MEDICINE, 2020, 99 (36) : E21976
[25] A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure
Xian, Shaoxiang
Yang, Zhongqi
Lee, Jun
Jiang, Zhiping
Ye, Xiaohan
Luo, Luyi
Jin, Lili
Yang, Tianlun
Ye, Suilin
Lu, Dongfeng
JOURNAL OF ETHNOPHARMACOLOGY, 2016, 186 : 136 - 142
[26] A RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF TERAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
LEPOR, H
AUERBACH, S
PURASBAEZ, A
NARAYAN, P
SOLOWAY, M
LOWE, F
MOON, T
LEIFER, G
MADSEN, P
JOURNAL OF UROLOGY, 1992, 148 (05): : 1467 - 1474
[27] Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
Parsons, Bruce
Pan, Xiaoping
Xie, Li
Chen, YuXuan
Ortiz, Marie
Whalen, Ed
JOURNAL OF PAIN RESEARCH, 2018, 11 : 1699 - 1708
[28] The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study
Pan, Jielu
Wang, Miao
Song, Haiyan
Wang, Lin
Ji, Guang
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
[29] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL ACYCLOVIR IN POSTHERPETIC NEURALGIA
SURMAN, OS
FLYNN, T
SCHOOLEY, RT
BAER, L
PARKER, S
HIRSCH, MS
DAVIS, LG
PSYCHOSOMATICS, 1990, 31 (03) : 287 - 292
[30] Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study
Wang, Hao
Romano, Gary
Fedgchin, Margaret
Russell, Lucille
Sanga, Panna
Kelly, Kathleen M.
Frustaci, Mary Ellen
Thipphawong, John
CLINICAL JOURNAL OF PAIN, 2017, 33 (02): : 99 - 108

← 1 2 3 4 5 →